Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. (2018)

First Author: Offman J
Attributed to:  Evidence Synthesis to inform health related decision making funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12885-018-4664-3

PubMed Identifier: 30075763

Publication URI: http://europepmc.org/abstract/MED/30075763

Type: Journal Article/Review

Volume: 18

Parent Publication: BMC cancer

Issue: 1

ISSN: 1471-2407